Aspiration Pneumonia — Complete MD Examination Answer (15 Marks)

1. INTRODUCTION & DEFINITION

• Approximately 50% of healthy adults aspirate small amounts during sleep without developing pneumonia, protected by intact pulmonary defense mechanisms.
• Aspiration pneumonia is the second leading cause of infection in nursing homes (after UTI), the leading cause of transfer from nursing home to hospital, and the leading cause of death in nursing home patients.
• It carries higher mortality (15–30%), longer hospital stay, and higher recurrence risk than community-acquired pneumonia (CAP).
• In polymyositis-dermatomyositis, it occurs in 10–20% of patients.

2. ETIOLOGY

A. Predisposing Conditions / Risk Factors

B. Causative Microorganisms

• Anaerobes (historically dominant — 90% of community-acquired cases): Prevotella spp., Fusobacterium spp., Bacteroides spp., Peptostreptococcus spp., microaerophilic streptococci
• Aerobes/facultative: Streptococcus pneumoniae, Staphylococcus aureus (MSSA), Haemophilus influenzae, Enterobacteriaceae (E. coli, Klebsiella pneumoniae)

• Gram-negative bacilli: Pseudomonas aeruginosa, Acinetobacter spp., ESBL-producing Klebsiella
• Gram-positive: MRSA, S. aureus
• Often polymicrobial

Important note: Recent data (IDSA-ATS 2019 guidelines; Fishman's Pulmonary) indicate that confirmed anaerobic infection is now increasingly uncommon (only ~0.5% of aspiration CAP had anaerobes isolated by culture), leading to the recommendation against routine anaerobic coverage unless lung abscess or empyema is present.

3. PATHOGENESIS

Step-by-Step Mechanism:

• Oropharyngeal or gastric contents are aspirated into the lower respiratory tract due to failure of protective airway reflexes (gag, cough, swallowing).

• Volume: Large-volume aspiration → asphyxia or acute ARDS
• pH: pH <2.5 → chemical pneumonitis (Mendelson's) precedes bacterial infection
• Bacterial load: Dependent on oral hygiene and colonization status

• Normal defenses (mucociliary clearance, alveolar macrophages, cough reflex, IgA secretion) are overwhelmed or impaired.

• Gastric acid causes direct epithelial injury → release of pro-inflammatory cytokines (IL-1, IL-6, TNF-α) → neutrophil influx → alveolar edema
• May progress to ARDS if massive

• Oropharyngeal bacteria colonize the damaged lung tissue → acute bronchopneumonia
• Anaerobes flourish in low-pH, necrotic environment; reduced local oxygen tension facilitates anaerobic growth
• Progression: bronchopneumonia → necrotizing pneumonia → lung abscess → empyema

• Aspiration pneumonia is bronchopneumonic in pattern
• Dependent lung segments are preferentially affected:
  • Supine position: posterior segment of upper lobes, superior segment of lower lobes (especially right)
  • Upright position: basal segments of lower lobes
  • Right side > left side (due to more vertical right main bronchus)

• Pulmonary alveolar septal thickening with type II pneumocyte hyperplasia
• Increased macrophages and organizing pneumonia within airspaces
• Vegetable matter may be seen in aspiration cases
• Necrotizing change is common → fulminant clinical course

4. CLINICAL FEATURES

A. Aspiration Pneumonitis (Acute Chemical, Mendelson's Syndrome)

• Rapid onset within hours of aspiration
• Shortness of breath, bronchospasm, hypoxia, tachypnea, low-grade fever
• Usually resolves within 24–48 hours if no bacterial superinfection
• May progress to ARDS in severe cases

B. Aspiration Pneumonia (Bacterial)

• Fever (may be low-grade in elderly/nursing home patients)
• Cough — may be productive with purulent or foul-smelling sputum (indicative of anaerobic infection)
• Dyspnea, tachypnea
• Chest pain (pleuritic if pleural involvement)
• Hemoptysis in anaerobic pleuropneumonia
• Fatigue, anorexia, weight loss in subacute presentations

• Tachycardia, tachypnea, fever, ± hypotension (severe disease)
• Rales, rhonchi, wheezes on auscultation over affected areas
• Signs of underlying precipitating condition (altered consciousness, neurological deficit)
• In nursing home patients: decreased appetite, weakness, altered sensorium — may appear non-toxic

• Lung abscess: foul-tasting/foul-smelling sputum, hemoptysis, cavitating lesion on CXR/CT
• Empyema: pleuritic chest pain, reduced breath sounds, dullness to percussion
• ARDS: diffuse bilateral infiltrates, severe hypoxemia, respiratory failure

C. Anaerobic Pleuropneumonia (subacute, 1–2 weeks post-aspiration):

• Fatigue, low-grade fever, weight loss, productive cough for weeks
• ~50% have putrid sputum (pathognomonic of anaerobic infection)
• Temperature up to 39°C
• Appears chronically ill/toxic

5. DIAGNOSIS

A. Clinical Diagnosis

• No single pathognomonic feature — aspiration pneumonia is clinically indistinguishable from non-aspiration pneumonia
• Diagnosis is strongly suggested by:
  • Predisposing risk factors (older age, nursing home, neurological disease, substance abuse)
  • Witnessed aspiration event
  • Foul-smelling sputum
  • Dependent lung zone infiltrates

B. Laboratory Investigations

C. Imaging

• Bronchopneumonic infiltrates — focal, segmental, or multilobar
• Right lower lobe most commonly affected (in semi-recumbent/upright)
• Posterior/superior segments of upper lobes and superior segments of lower lobes (in supine)
• Lung abscess: thick-walled cavity with air-fluid level
• Empyema: pleural effusion with loculation

• More sensitive than CXR
• Shows: posterior/peribronchiolar opacities, peripheral consolidation, lung abscess (cavitation with air-fluid level), interlobular septal thickening, ground-glass opacities
• CT is indicated to evaluate for lung abscess, foreign body, or empyema

D. Special Investigations

• Swallowing evaluation (modified barium swallow / videofluoroscopy) — for suspected dysphagia
• Fiberoptic endoscopic evaluation of swallowing (FEES) — gold standard for swallow dysfunction assessment
• Bronchoscopy — for foreign body removal, protected brush specimen culture in ICU/intubated patients
• Pleural tap — if effusion present: send for pH, LDH, glucose, protein, Gram stain, culture

6. TREATMENT

A. General Measures & Supportive Care

1. Airway management: Position patient with head elevated (30–45°); suction oropharynx
2. Oxygen supplementation: Maintain SpO₂ >94%; use nasal cannula, face mask, or Venturi mask
3. Mechanical ventilation: ARDS or respiratory failure → intubation with lung-protective ventilation (tidal volume 6 mL/kg IBW)
4. IV fluids: Correct dehydration while avoiding fluid overload
5. Bronchodilators: For aspiration-induced bronchospasm (salbutamol/albuterol MDI or nebulization)
6. Nutritional support: NPO initially if aspiration risk active; then feeding via NGT or jejunostomy
7. Oral hygiene: Tooth brushing, chlorhexidine oral rinse — reduces bacterial load; benefit in reducing pneumonia is adjunctive

B. Antibiotic Therapy with Dosages

Community-Acquired Aspiration Pneumonia (Empirical — no lung abscess/empyema):

First-line options (Goldman-Cecil Medicine):

Oral step-down therapy:

• Clindamycin 600 mg three times daily, OR
• Amoxicillin-clavulanate 625–875 mg three times daily
• To complete 7–10-day total course

Health Care-Associated / Hospital-Acquired Aspiration Pneumonia:

• If MDR risk: Add Vancomycin 15 mg/kg IV q12h (target trough 10–15 μg/mL) or Linezolid 600 mg IV q12h for MRSA
• If Pseudomonas suspected: use antipseudomonal β-lactam + fluoroquinolone (dual coverage)

IDSA-ATS current guideline note: Routine anaerobic coverage is NOT recommended in aspiration pneumonia without lung abscess or empyema.

Lung Abscess:

C. Management of Complications

D. Prevention

1. Positioning: Semi-recumbent (30–45°) position, especially during tube feeding
2. Oral hygiene: Regular tooth brushing, professional dental care for institutionalized patients
3. Swallowing therapy: Speech-language pathology assessment + rehabilitation
4. Medication review: Minimize sedatives, anticholinergics, antipsychotics where possible
5. H2 blockers/PPIs: For patients with severe GERD
6. Avoid prolonged supine positioning
7. Fundoplication: For refractory GERD in selected cases (e.g., pre-transplant patients)
8. Chlorhexidine oral rinse: Adjunctive in ventilated patients

7. PROGNOSIS

• Mortality: 15–30% for hospitalized aspiration pneumonia
• Lung abscess mortality: ~20%
• Anaerobic aspiration pneumonia (severe): mortality up to 36%
• Prognosis is largely determined by underlying predisposing conditions (neurological disease, malignancy, immunosuppression) rather than the aspiration event itself
• Uncomplicated cases with adequate antibiotic treatment generally respond promptly

Summary Table for Quick Revision

• Goldman-Cecil Medicine, International Edition
• Tintinalli's Emergency Medicine: A Comprehensive Study Guide
• Murray & Nadel's Textbook of Respiratory Medicine
• Fishman's Pulmonary Diseases and Disorders
• Robbins & Kumar Basic Pathology / Robbins Cotran Pathologic Basis of Disease
• Rosen's Emergency Medicine: Concepts and Clinical Practice